These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
334 related articles for article (PubMed ID: 27038728)
1. The role of epigenetic modifications in cardiovascular disease: A systematic review. Muka T; Koromani F; Portilla E; O'Connor A; Bramer WM; Troup J; Chowdhury R; Dehghan A; Franco OH Int J Cardiol; 2016 Jun; 212():174-83. PubMed ID: 27038728 [TBL] [Abstract][Full Text] [Related]
2. The role of global and regional DNA methylation and histone modifications in glycemic traits and type 2 diabetes: A systematic review. Muka T; Nano J; Voortman T; Braun KVE; Ligthart S; Stranges S; Bramer WM; Troup J; Chowdhury R; Dehghan A; Franco OH Nutr Metab Cardiovasc Dis; 2016 Jul; 26(7):553-566. PubMed ID: 27146363 [TBL] [Abstract][Full Text] [Related]
3. The role of DNA methylation and histone modifications in blood pressure: a systematic review. Gonzalez-Jaramillo V; Portilla-Fernandez E; Glisic M; Voortman T; Bramer W; Chowdhury R; Roks AJM; Jan Danser AH; Muka T; Nano J; Franco OH J Hum Hypertens; 2019 Oct; 33(10):703-715. PubMed ID: 31346255 [TBL] [Abstract][Full Text] [Related]
4. The Role of DNA Methylation and Histone Modifications in Neurodegenerative Diseases: A Systematic Review. Wen KX; Miliç J; El-Khodor B; Dhana K; Nano J; Pulido T; Kraja B; Zaciragic A; Bramer WM; Troup J; Chowdhury R; Ikram MA; Dehghan A; Muka T; Franco OH PLoS One; 2016; 11(12):e0167201. PubMed ID: 27973581 [TBL] [Abstract][Full Text] [Related]
5. DNA methylation and cardiovascular disease in humans: a systematic review and database of known CpG methylation sites. Krolevets M; Cate VT; Prochaska JH; Schulz A; Rapp S; Tenzer S; Andrade-Navarro MA; Horvath S; Niehrs C; Wild PS Clin Epigenetics; 2023 Mar; 15(1):56. PubMed ID: 36991458 [TBL] [Abstract][Full Text] [Related]
6. Epigenetic-related therapeutic challenges in cardiovascular disease. Schiano C; Vietri MT; Grimaldi V; Picascia A; De Pascale MR; Napoli C Trends Pharmacol Sci; 2015 Apr; 36(4):226-35. PubMed ID: 25758254 [TBL] [Abstract][Full Text] [Related]
7. DNA methylation and incident cardiovascular disease. Westerman KE; Ordovás JM Curr Opin Clin Nutr Metab Care; 2020 Jul; 23(4):236-240. PubMed ID: 32487875 [TBL] [Abstract][Full Text] [Related]
8. Association between global leukocyte DNA methylation and cardiovascular risk in postmenopausal women. Ramos RB; Fabris V; Lecke SB; Maturana MA; Spritzer PM BMC Med Genet; 2016 Oct; 17(1):71. PubMed ID: 27724854 [TBL] [Abstract][Full Text] [Related]
9. DNA methylation modules associate with incident cardiovascular disease and cumulative risk factor exposure. Westerman K; Sebastiani P; Jacques P; Liu S; DeMeo D; Ordovás JM Clin Epigenetics; 2019 Oct; 11(1):142. PubMed ID: 31615550 [TBL] [Abstract][Full Text] [Related]
10. Effects of early- and mid-life stress on DNA methylation of genes associated with subclinical cardiovascular disease and cognitive impairment: a systematic review. Vidrascu EM; Bashore AC; Howard TD; Moore JB BMC Med Genet; 2019 Mar; 20(1):39. PubMed ID: 30866842 [TBL] [Abstract][Full Text] [Related]
11. Transgenerational inheritance: how impacts to the epigenetic and genetic information of parents affect offspring health. Xavier MJ; Roman SD; Aitken RJ; Nixon B Hum Reprod Update; 2019 Sep; 25(5):518-540. PubMed ID: 31374565 [TBL] [Abstract][Full Text] [Related]
12. Type 2 diabetes mellitus in relation to global LINE-1 DNA methylation in peripheral blood: a cohort study. Martín-Núñez GM; Rubio-Martín E; Cabrera-Mulero R; Rojo-Martínez G; Olveira G; Valdés S; Soriguer F; Castaño L; Morcillo S Epigenetics; 2014 Oct; 9(10):1322-8. PubMed ID: 25437047 [TBL] [Abstract][Full Text] [Related]
13. Therapeutic Potential of Natural Compounds Acting through Epigenetic Mechanisms in Cardiovascular Diseases: Current Findings and Future Directions. Bontempo P; Capasso L; De Masi L; Nebbioso A; Rigano D Nutrients; 2024 Jul; 16(15):. PubMed ID: 39125279 [TBL] [Abstract][Full Text] [Related]
14. Treatment of cardiovascular pathology with epigenetically active agents: Focus on natural and synthetic inhibitors of DNA methylation and histone deacetylation. Chistiakov DA; Orekhov AN; Bobryshev YV Int J Cardiol; 2017 Jan; 227():66-82. PubMed ID: 27852009 [TBL] [Abstract][Full Text] [Related]
15. The role of redox signaling in epigenetics and cardiovascular disease. Kim GH; Ryan JJ; Archer SL Antioxid Redox Signal; 2013 May; 18(15):1920-36. PubMed ID: 23480168 [TBL] [Abstract][Full Text] [Related]
17. DNA methylation processes in atheosclerotic plaque. Aavik E; Babu M; Ylä-Herttuala S Atherosclerosis; 2019 Feb; 281():168-179. PubMed ID: 30591183 [TBL] [Abstract][Full Text] [Related]
18. Adipose Tissue Epigenetic Profile in Obesity-Related Dysglycemia - A Systematic Review. Andrade S; Morais T; Sandovici I; Seabra AL; Constância M; Monteiro MP Front Endocrinol (Lausanne); 2021; 12():681649. PubMed ID: 34290669 [TBL] [Abstract][Full Text] [Related]
19. Impact of epigenetics in the management of cardiovascular disease: a review. Cao Y; Lu L; Liu M; Li XC; Sun RR; Zheng Y; Zhang PY Eur Rev Med Pharmacol Sci; 2014 Oct; 18(20):3097-104. PubMed ID: 25392111 [TBL] [Abstract][Full Text] [Related]
20. [Epigenetics' implication in autism spectrum disorders: A review]. Hamza M; Halayem S; Mrad R; Bourgou S; Charfi F; Belhadj A Encephale; 2017 Aug; 43(4):374-381. PubMed ID: 27692350 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]